Related Experiment Video
Updated: Jun 13, 2026
08:43
Adoptive Immunotherapy of iNKT Cells in Glucose-6-Phosphate Isomerase (G6PI)-Induced RA Mice
Published on: January 31, 2020
IL-6: from its discovery to clinical applications
1Laboratory of Immune Regulation, Graduate School of Frontier Biosciences, Osaka University, Osaka, Japan. kishimot@fbs.osaka-u.ac.jp
International Immunology
|April 23, 2010
Summary
Researchers discovered Interleukin-6 (IL-6) as a key factor in B cell activation and antibody production. This cytokine is now a therapeutic target for autoimmune diseases and cancer.
Area of Science:
- Immunology
- Molecular Biology
- Biochemistry
Background:
- T cell involvement in antibody production necessitates B cell activating factors.
- Early research hypothesized T-cell-derived soluble factors crucial for B cell activation.
Observation:
- The factor inducing immunoglobulin production in B cells was identified as B-cell stimulatory factor-2.
- B-cell stimulatory factor-2 was cloned in 1986 and is now known as Interleukin-6 (IL-6).
- IL-6 was independently identified as IFN-beta2, a 26-kDa fibroblast protein, hybridoma/plasmacytoma growth factor, and hepatocyte-stimulating factor.
Findings:
- IL-6 is a pleiotropic cytokine regulating immune responses, hematopoiesis, inflammation, and oncogenesis.
- Subsequent research elucidated IL-6's diverse activities, its receptor system (IL-6R), and signal transduction pathways.
- A humanized anti-IL-6R antibody therapy demonstrates efficacy in treating rheumatoid arthritis, systemic juvenile idiopathic arthritis, and Castleman's disease.
Implications:
- The discovery and characterization of IL-6 exemplify the progression from basic scientific research to clinical applications.
- Targeting IL-6 signaling offers a promising therapeutic strategy for various immune-mediated and inflammatory conditions.
- Understanding IL-6's multifaceted roles opens avenues for novel treatments in oncology and hematology.
Related Concept Videos
01:22iPS Cell Differentiation
The ability of induced pluripotent stem cells or iPSCs to differentiate into most body cell types has stimulated repair and regenerative medicine research over the past few decades. iPSC-derived blood cells, hepatocytes, beta islet cells, cardiomyocytes, neurons, and other cell types can repair injuries or regenerate damaged tissue in diseases such as diabetes and neurodegenerative disorders.
01:11Clinical Trials: Overview
Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
01:25Rapid Identification of Pathogens
MALDI-TOF MS has transformed clinical microbiology by offering a rapid and reliable method for pathogen identification. The traditional approach to microbial identification typically involves time-consuming culture techniques and biochemical tests, which can delay the initiation of appropriate antimicrobial therapy. MALDI-TOF MS avoids these delays by using characteristic ribosomal protein mass patterns of microbial cells, enabling accurate species-level identification within minutes.Principle...
01:28Preclinical Development: Overview
Preclinical development consists of a series of tests that ensure the safety and efficacy of a new therapeutic compound before it is tested in humans. There are four main phases to this process. First, safety pharmacology tests are conducted to ensure the drug does not produce any acutely harmful effects. These tests examine parameters such as bronchoconstriction, cardiac dysrhythmias, blood pressure changes, and ataxia. Next, preliminary toxicological testing is performed to determine the...
01:29Microorganisms in Medicine and Therapeutics
Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.
01:21EPS and iPS Cells in Disease Research
Embryonic and induced pluripotent stem cells are excellent models for disease research because of their ability to self-renew and differentiate into most cell types. Somatic cells from a patient are isolated and reprogrammed into induced pluripotent stem cells or iPSCs. These iPSCs are later differentiated into the desired cell type, which mirrors the diseased cell of the patient. In this way, disease models have been created for investigating diseases such as Down syndrome, type I diabetes,...